1. Home
  2. VIRT vs JSPRW Comparison

VIRT vs JSPRW Comparison

Compare VIRT & JSPRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIRT
  • JSPRW
  • Stock Information
  • Founded
  • VIRT 2008
  • JSPRW N/A
  • Country
  • VIRT United States
  • JSPRW United States
  • Employees
  • VIRT N/A
  • JSPRW N/A
  • Industry
  • VIRT Investment Bankers/Brokers/Service
  • JSPRW Biotechnology: Pharmaceutical Preparations
  • Sector
  • VIRT Finance
  • JSPRW Health Care
  • Exchange
  • VIRT Nasdaq
  • JSPRW Nasdaq
  • Market Cap
  • VIRT N/A
  • JSPRW N/A
  • IPO Year
  • VIRT 2015
  • JSPRW N/A
  • Fundamental
  • Price
  • VIRT $35.39
  • JSPRW $0.12
  • Analyst Decision
  • VIRT Buy
  • JSPRW
  • Analyst Count
  • VIRT 7
  • JSPRW 0
  • Target Price
  • VIRT $31.36
  • JSPRW N/A
  • AVG Volume (30 Days)
  • VIRT 1.0M
  • JSPRW 7.8K
  • Earning Date
  • VIRT 01-29-2025
  • JSPRW 03-05-2025
  • Dividend Yield
  • VIRT 2.70%
  • JSPRW N/A
  • EPS Growth
  • VIRT 109.16
  • JSPRW N/A
  • EPS
  • VIRT 2.97
  • JSPRW N/A
  • Revenue
  • VIRT $2,220,491,000.00
  • JSPRW N/A
  • Revenue This Year
  • VIRT N/A
  • JSPRW N/A
  • Revenue Next Year
  • VIRT $3.47
  • JSPRW N/A
  • P/E Ratio
  • VIRT $11.95
  • JSPRW N/A
  • Revenue Growth
  • VIRT 31.91
  • JSPRW N/A
  • 52 Week Low
  • VIRT $16.80
  • JSPRW $0.15
  • 52 Week High
  • VIRT $41.38
  • JSPRW $0.16
  • Technical
  • Relative Strength Index (RSI)
  • VIRT 37.66
  • JSPRW N/A
  • Support Level
  • VIRT $36.38
  • JSPRW N/A
  • Resistance Level
  • VIRT $39.39
  • JSPRW N/A
  • Average True Range (ATR)
  • VIRT 1.31
  • JSPRW 0.00
  • MACD
  • VIRT -0.41
  • JSPRW 0.00
  • Stochastic Oscillator
  • VIRT 0.33
  • JSPRW 0.00

About JSPRW Japer Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Share on Social Networks: